Stocks · News reference
Elevra Lithium Executes 7-Year Agreement With Mangrove Lithium For Supply Of Spodumene Concentrate Manufacture At North American Lithium in Quebec
North American lithium producer Elevra Lithium Limited ("Elevra") ((ASX:ELV, NASDAQ:ELVR) is pleased to announce that it has executed a binding Spodumene Concentrate Supply Agreement (the "Agreement")
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 21, 2026, 1:01 PM
- Checked
- Aug 21, 2026, 1:01 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Elevra Lithium shares are trading higher after the company announced a binding Spodumene Concentrate Supply Agreement with Mangrove for the long-term supply of spodumene concentrate produced at North American Lithium in Québec.
Read original at benzingaElevra Lithium Completes Sale of E45/2364 Pegmatite Rights
Elevra Lithium has completed the sale of its E45/2364 exploration rights in Western Australia to Wildcat Resources for A$16 million in total consideration, including A$5 million cash upfront, A$8 million in Wildcat shares, A$3 million deferred cash, and contingent royalty payments. The transaction allows Elevra to reallocate capital to its core North American lithium assets while maintaining upside exposure through royalty participation.
Read original at globenewswire-inc